Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

GlaxoSmithKline · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
arthritisplaceborheumatoidrheumatoid-arthritis
arthritis, rheumatoid, rheumatoid arthritis, gsk3196165, otilimab, tofacitinib, methotrexate, placebo, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 855056
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.